These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 6747778)
21. ASHP guidelines on compounding sterile preparations. American Society of Health System Pharmacists Am J Health Syst Pharm; 2014 Jan; 71(2):145-66. PubMed ID: 24375608 [No Abstract] [Full Text] [Related]
22. Aseptic work under various hygienic conditions. Aslund B; Olson OT; Sandell E Acta Pharm Suec; 1977; 14(5-6):517-24. PubMed ID: 596167 [No Abstract] [Full Text] [Related]
24. [Control of microbial contamination in the air of rooms for sterile production. Proposals for sampling]. Carazzone M; Fava M Boll Chim Farm; 1981 Jul; 120(7):416-26. PubMed ID: 7317168 [No Abstract] [Full Text] [Related]
25. Aerobiological model for assessing microbial contamination. Lipscomb B; Avis KE J Parenter Drug Assoc; 1979; 33(1):3-16. PubMed ID: 253025 [No Abstract] [Full Text] [Related]
26. Smith Kline & French Laboratories, Philadelphia, Pa. Sterile Operations facility. Blackmer RA J Parenter Sci Technol; 1984; 38(5):183-9. PubMed ID: 6512656 [No Abstract] [Full Text] [Related]
27. [Atmospheric control in the pharmaceutical industry]. Alexis J; Brouwers L; Calay-Mertens MT; Capel-Boute C; Cooper TG; De Maeyer-Cleempoel S; Houtart B; Ledger I; Lhoest W; Rappe A J Pharm Belg; 1975; 30(4):325-30. PubMed ID: 1107511 [No Abstract] [Full Text] [Related]
28. Sterile filling facility--its design, construction and operation. Kiritsy PA; Engvall R Bull Parenter Drug Assoc; 1973; 27(6):279-86. PubMed ID: 4755788 [No Abstract] [Full Text] [Related]
30. Design and construction of an Australian sterile products plant. Woods AD Bull Parenter Drug Assoc; 1975; 29(1):26-38. PubMed ID: 1125471 [No Abstract] [Full Text] [Related]
31. Airborne microbial challenges of Blow/Fill/Seal equipment: a case study. Bradley A; Probert SP; Sinclair CS; Tallentire A J Parenter Sci Technol; 1991; 45(4):187-92. PubMed ID: 1770413 [TBL] [Abstract][Full Text] [Related]
32. The advisory role of FDA district offices in the planning of a new parenteral facility. Tetzlaff RF J Parenter Sci Technol; 1984; 38(3):94-7. PubMed ID: 6747781 [No Abstract] [Full Text] [Related]
33. Persistent isolation of an unusual Pseudomonas species from a phenolic disinfectant system. Newman KA; Tenney JH; Oken HA; Moody MR; Wharton R; Schimpff SC Infect Control; 1984 May; 5(5):219-22. PubMed ID: 6563020 [TBL] [Abstract][Full Text] [Related]
34. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Production in bigger plants]. Schnorf U Pharm Acta Helv; 1973 Feb; 48(2):83-100. PubMed ID: 4706311 [No Abstract] [Full Text] [Related]
35. Reducing the risk of contamination of sterile parenteral products via ready-to-use closure components. Curry W; Conway S; Goodfield C; Miller K; Mueller RL; Polini E AAPS PharmSciTech; 2010 Dec; 11(4):1572-9. PubMed ID: 21057904 [TBL] [Abstract][Full Text] [Related]
36. A modern research laboratory for sterile preparations. Anschel J; Nagy IE Bull Parenter Drug Assoc; 1974; 28(3):136-45. PubMed ID: 4845937 [No Abstract] [Full Text] [Related]
37. Steam sterilization of L.Y.P.'s: an integrated approach to sterilization assurance. Mascoli CC J Pharm Belg; 1977; 32(5):516-9. PubMed ID: 609038 [No Abstract] [Full Text] [Related]
38. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Claims of IKS principles]. Witschi T Pharm Acta Helv; 1973 Feb; 48(2):53-62. PubMed ID: 4706309 [No Abstract] [Full Text] [Related]